Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 8, Pages 1810-1820
Publisher
Wiley
Online
2016-06-13
DOI
10.1002/cam4.754
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic value of serum B7-H4 for hepatocellular carcinoma
- (2015) Cheng Zhang et al. JOURNAL OF SURGICAL RESEARCH
- The Future of Cancer Therapy: Selecting Patients Likely to Respond to PD1/L1 Blockade
- (2014) A. Ribas et al. CLINICAL CANCER RESEARCH
- Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial
- (2014) T. K. Choueiri et al. CLINICAL CANCER RESEARCH
- Potential of New Therapies like Anti-PD1 in Kidney Cancer
- (2014) Anasuya Gunturi et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
- (2014) Akinori Masuda et al. Biomed Research International
- Cancer Immunotherapy Highlights from the 2014 ASCO Meeting
- (2014) L. C. Harshman et al. Cancer Immunology Research
- The Path to Reactivation of Antitumor Immunity and Checkpoint Immunotherapy
- (2014) H.-J. Kim et al. Cancer Immunology Research
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- Host B7x Promotes Pulmonary Metastasis of Breast Cancer
- (2013) Y. M. Abadi et al. JOURNAL OF IMMUNOLOGY
- The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus
- (2013) L Zhang et al. ONCOGENE
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell Carcinoma
- (2011) X. Frigola et al. CLINICAL CANCER RESEARCH
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
- (2008) R. H. Thompson et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now